A Few Drops of Sugar Water Ease Pain in Newborns. Hospitals Are Still Not Using It Consistently.

Newborn babies in intensive care units can undergo dozens of needle procedures in a single week. Blood draws, IV placements, heel-prick tests - each one painful, each one performed on an infant whose nervous system is still developing and whose capacity for pain regulation is minimal. For years, many of these procedures have been done with no pain relief at all.

The frustrating part is that a simple, cheap intervention has been sitting in the evidence base for decades: a small amount of sucrose solution, placed in the baby's mouth a couple of minutes before the needle, appears to reduce pain. A Cochrane review published this month looked at 29 clinical trials involving more than 2,700 preterm and full-term infants and confirmed that the evidence is probably strong enough to act on. The harder question is why hospitals are still not using it consistently.

What the review found

The primary focus was venepuncture - drawing blood from a vein, typically for testing - which is one of the most common needle procedures in neonatal care. Sucrose, compared to no treatment, water, or standard care, probably reduces pain during and immediately after the procedure. The evidence quality is rated as moderate, meaning the researchers are fairly but not completely confident the effect is real.

The effect appears to be enhanced when sucrose is combined with non-nutritive sucking - having the infant suck on a pacifier at the same time. The two together seem to work better than either alone, likely because sucking activates separate pain-modulating pathways distinct from those triggered by sweetness.

None of the 29 trials reported immediate adverse effects from sucrose at the small doses used for pain relief. That is reassuring, though the studies primarily measured short-term outcomes. The longer-term effects of repeated sucrose administration in infants who spend weeks or months in neonatal care remain understudied.

The gap between evidence and practice

"Newborn babies undergo frequent needle procedures in hospital without any pain relief or comforting measures, even though older children and adults rarely have these procedures done without pain care," said lead author Mariana Bueno from the University of Toronto. "The evidence shows that a small amount of sucrose given just before the procedure is a simple, fast and effective way to reduce that pain."

The review identified considerable variation in how sucrose is given when it is used - differences in dose, timing, and whether it is paired with other comfort measures like a pacifier. That inconsistency matters: if the intervention works best when given at a specific dose and timed precisely before the procedure, ad hoc application will underperform the clinical trial results.

Co-author Jiale Hu from Virginia Commonwealth University emphasized the need for formal protocols: "To ensure safety and clinical consistency, sucrose must be administered under formal medication protocols that define specific timing and dosage for painful procedures." The review authors also flag an important distinction - sucrose should be reserved for actual painful procedures and documented properly, not used routinely to settle a crying baby, which would risk both overuse and losing track of cumulative exposure.

What parents should know

"Parents may be surprised to learn that something as simple as a few drops of sugar solution can make a real difference to their baby's comfort during blood tests," said co-author Ligyana Candido from the University of Ottawa. The intervention is especially relevant in situations where skin-to-skin contact or breastfeeding - the other well-supported comfort interventions - are not possible because of the infant's condition or the clinical setting.

Parents are generally entitled to ask whether pain management is being provided during their newborn's procedures. The Cochrane review gives clinicians a clearer evidence base to point to when discussing options.

What still needs to be studied

The review authors identify two priorities for future research. First, head-to-head comparisons between effective comfort measures - sucrose versus skin-to-skin contact versus breastfeeding - rather than continuing to compare all of them to no treatment. Second, longer-term follow-up studies tracking infants who received repeated sucrose doses across extended NICU stays. The absence of immediate side effects is encouraging; what happens to pain processing and neurodevelopment over months and years in heavily treated infants is still genuinely unknown.